Undeberg Megan R, Barash Alanda, McKeirnan Kimberly C
Washington State University College of Pharmacy and Pharmaceutical Sciences, 412 E. Spokane Falls Blvd, Spokane, WA 99202-2131, USA.
Explor Res Clin Soc Pharm. 2023 Aug 24;11:100324. doi: 10.1016/j.rcsop.2023.100324. eCollection 2023 Sep.
This case report describes the pharmacist intervention with a 62-year-old woman who had postmenopausal breast cancer. The patient was experiencing severe vasomotor symptoms from her cancer therapy and wanted to discontinue her treatment despite her risk of cancer returning. Using guidelines for treatment of postmenopausal breast cancer and medication options to mitigate vasomotor symptoms, the pharmacist developed a treatment plan that was acceptable to the patient and approved by the oncologist. Following implementation, the patient was satisfied to experience minimal hot flashes and relayed full compliance with her breast cancer treatment regimen. Pharmacists can play an important role in the management of postmenopausal breast cancer and vasomotor symptoms by providing patient education and recommending medications based on treatment guidelines with consideration to side effects and drug interactions.
本病例报告描述了药剂师对一名62岁绝经后乳腺癌女性的干预情况。该患者因癌症治疗出现严重的血管舒缩症状,尽管有癌症复发风险,她仍希望停止治疗。药剂师依据绝经后乳腺癌治疗指南及缓解血管舒缩症状的药物选择,制定了一个患者可接受且经肿瘤学家批准的治疗方案。实施该方案后,患者对潮热症状减轻感到满意,并表示完全遵守其乳腺癌治疗方案。药剂师可通过提供患者教育,并根据治疗指南推荐药物,同时考虑副作用和药物相互作用,在绝经后乳腺癌及血管舒缩症状的管理中发挥重要作用。